Khaleghi Mehr Farhood, Abian Nasrollah, Rahimi Mandana, Moradi Yasaman
Department of Urology, Hasheminejad Kidney Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Department of Urology, 5Azar Hospital, School of Medicine, Golestan University of Medical Sciences and Health Services, Gorgan, Iran.
Int J Surg Case Rep. 2023 Dec;113:109053. doi: 10.1016/j.ijscr.2023.109053. Epub 2023 Nov 13.
Malignant rhabdoid tumor of kidney (MRTK) is almost exclusive to children. Only 10 cases of adult MRTK have been reported. Here, we present a case of MRTK in an adult patient and discuss its clinical findings, diagnostic challenges, and treatment outcome. We also perform literature review on this issue.
Our patient was a 29-year-old woman presented with fever and hematuria. She also mentioned atypical teratoid/rhabdoid tumor of cerebellum in her deceased child. Initial diagnostic work up led to left partial nephrectomy with the pathology report of high grade undifferentiated tumor. Early tumor recurrence necessitated left radical nephrectomy with extensive excision of adjacent tissues. Pathology for second specimen considering disease course and family history was MRTK. Even though chemotherapy was administered, she died few months later due to multiple metastases.
Although diagnosis is challenging in all 11 reported cases -including our case- of adult MRTK, immunohistochemistry (i.e., negative reaction for INI-1) in conjunction with clinical and radiological findings are the main tool to reach diagnosis. Treatment options are much more diverse, ranging from surgery to immunotherapy, tyrosine kinase inhibitors, chemotherapy, and combination of these modalities. Prognosis remains dismal with the mean survival period of 7 months.
Although extremely rare, MRTK might happen in adults. We report the first case of adult MRTK with positive family history of rhabdoid tumor of CNS, underscoring the importance of family history in reaching the diagnosis and highlighting the role of genetics in this rare disease.
肾恶性横纹肌样瘤(MRTK)几乎仅见于儿童。仅报道过10例成人MRTK病例。在此,我们报告一例成人患者的MRTK病例,并讨论其临床发现、诊断挑战及治疗结果。我们还对该问题进行了文献综述。
我们的患者是一名29岁女性,出现发热和血尿症状。她还提到其已故孩子患有小脑非典型畸胎样/横纹肌样瘤。初步诊断检查导致行左肾部分切除术,病理报告为高级别未分化肿瘤。早期肿瘤复发需要行左肾根治性切除术并广泛切除相邻组织。考虑到病程和家族史,第二个标本的病理检查结果为MRTK。尽管进行了化疗,但她几个月后因多处转移而死亡。
在包括我们病例在内的所有11例报道的成人MRTK病例中,尽管诊断具有挑战性,但免疫组化(即INI-1阴性反应)结合临床和影像学发现是达成诊断的主要工具。治疗选择更加多样,从手术到免疫治疗、酪氨酸激酶抑制剂、化疗以及这些方式的联合应用。预后仍然很差,平均生存期为7个月。
尽管极为罕见,但MRTK可能发生在成人身上。我们报告了首例有中枢神经系统横纹肌样瘤家族史阳性的成人MRTK病例,强调了家族史在诊断中的重要性,并突出了遗传学在这种罕见疾病中的作用。